Chronic Stable Angina
Conditions
Interventions
DLT-SML:Oral Danlou tablets and iv. Salvia miltiorrhiza ligustrazine injection
Sponsors
Traditional Chinese Medicine Hospital of Tailai County, Qiqihar City, Heilongjiang Province
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged between 40-85 years; 2. Meets the diagnostic criteria for Chronic Stable Angina; 3. suffered from angina for more than 3 years 4. singed the consent form.
Exclusion criteria
Exclusion criteria: 1. Combined with Congenital heart disease, rheumatic heart disease, unstable angina pectoris; 2. Combined with Valvular disease, suspected major artery dissection, arrhythmia, acute heart failure, moderate to severe pulmonary hypertension, acute pulmonary embolism and other serious cardiopulmonary dysfunction; 3. Combined with Severe liver and kidney dysfunction, immune diseases; 4. Combined with acute infection; 5. Patients who used antibiotics, other lipid-lowering and blood-glucose lowering drugs and other Chinese medicines before 2 weeks and during the experiment; 6. Involuntary patients, poor compliance; 7. Participated in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL-1ß; | — |
Secondary
| Measure | Time frame |
|---|---|
| lipid panel (TG, TC, HDL-c, and LDL-c), GLU;inflammation cytokines (IL-6, IL-10, TNF-a);gut-derived metabolites (LPS, TMAO) level;gut microbiota; | — |
Countries
China
Contacts
Public ContactLi Yuhong
Tianjin University of Traditional Chinese Medicine
Outcome results
None listed